Associated Marketing Concepts

Private Company, Headquarters Location
21624 Marilla St., Chatsworth, CA 91311-4123, United States
(800)270-4262, (818)678-1651, (818)678-1655 fax, http://www.ambassador-amc.com

Primary SIC: Vitreous Plumbing Fixtures, Primary NAICS: Vitreous China Plumbing Fixture and China and Earthenware Fitting and Bathroom Accessories Manufacturing
Description: Vitreous Plumbing Fixtures

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

Associated Marketing Concepts, News and Information

'Broadway' lights to brighten El Segundo nights
Daily Breeze; 12/25/2009; 937 words; ...perform." Cason, who now works as a marketing director for a corporate events company...bringing Broadway to El Segundo after the concept occurred in a "light-bulb moment...arts and culture niche in a city mostly associated with contributions to the aerospace industry...

Stop-Smoking Gum Launches New Campaign Showing Smokers How Quitting Can 'Suck Less'.
Biotech Week; 12/23/2009; 1222 words; ...view the multimedia assets associated with this release, please...easy," said Michael Roe, Marketing Director of the U.S. Smoking...through the process." The concept behind the campaign is to...Entertainment, GlaxoSmithKline, Marketing, Nicorette, Nicorette Therapy...

Cannasat Therapeutics Announces Debt for Shares Settlement.
Marketwire Canada; 12/22/2009; 849 words; ...may be used to treat neuropathic pain associated with multiple sclerosis and cancer...advance projects to Phase 2 proof-of-concept clinical studies. Once the drug candidates...the programs to the appropriate Pharma marketing partners for a combination of upfront...

Eisai Buying AkaRx for $255M; Gaining Phase II Drug for ITP.
BIOWORLD Today; 12/21/2009; 949 words; ...for its pipeline. The big biotech was marketing Aloxi (palonosetron hydrochloride...II for both ITP and thrombocytopenia associated with liver diseases. Additional trials...Eisai has achieved clinical proof of concept in the ITP setting. And so, with three...

Neurocrine Advances VMAT2 Inhibitor Program.
PR Newswire; 12/21/2009; 1019 words; ...for Phase 2 proof of concept trial to be initiated...minimize side effects associated with excessive dopamine...risks and uncertainties associated with Neurocrine's...risks and uncertainties associated with the Company's...commercial manufacturing and marketing and sales activities...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.